Coventry University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes
"entrepreneur"×
10 miles

Medical / Clinical Science (entrepreneur) PhD Projects, Programs & Scholarships

We have 9 Medical / Clinical Science (entrepreneur) PhD Projects, Programs & Scholarships

  • "entrepreneur" ×
  • Medical / Clinical Science×
  • clear all
Order by 
Showing 1 to 9 of 9
  Role of pentraxin and interaction with complement in immune defence against opportunistic infections
  Prof C Garlanda, Prof S Meri
Application Deadline: 10 November 2019

Funding Type

PhD Type

PTX3 is a soluble pattern recognition molecule which acts as a key component of humoral innate immunity in opportunistic infections of fungal and bacterial origin.
  Identification of novel complement evasion mechanisms developed by bacterial pathogens
  Prof A Blom, Prof S Rooijakkers
Application Deadline: 10 November 2019

Funding Type

PhD Type

The project is focused on discovery of new complement evasion mechanisms developed by bacterial pathogens. One of the studied bacteria will be opportunistic Filifactor alocis, a recently identified periodontal pathogen of major importance but still poorly studied.
  Generation, characterisation and commercialisation of native-restricted and neoepitope-specific monoclonal antibodies directed against the terminal complement protein C7
  Prof R Würzner, Prof Z Prohaszka
Application Deadline: 10 November 2019

Funding Type

PhD Type

Complement is one of the most important players in innate immune defense. Three activation pathways are triggered by multiple interactions and are amplified in cascades, leading to the activation of the terminal complement (TC) pathway.
  Influence of HIV-1 opsonization on APC functions with regard to persistence of the virus and opportunistic pathogens, such as Mycobacteria spp. within relevant human 3D models
  Prof D Wilflingseder, Prof S Niemann
Application Deadline: 10 November 2019

Funding Type

PhD Type

HIV-1 and Mycobacterium tuberculosis represent detrimental co-epidemics worldwide, particularly in sub-Saharan Africa, and co-infection accelerates progression of both diseases.
  Development of immunoassays for specific classical and lectin pathway activation markers
  Prof Z Prohaszka, Prof R Würzner
Application Deadline: 10 November 2019

Funding Type

PhD Type

Infections and various immune-inflammation mediated conditions are characterized by the activation of the complement system. Antibodies (immune complexes) activate the classical pathway whereas repetitive carbohydrate structures give rise to the initiation of the lectin pathway.
  Complement resistance mechanisms by multi-drug resistant Klebsiella pneumonia
  Prof S Rooijakkers, Prof A Blom
Application Deadline: 10 November 2019

Funding Type

PhD Type

The aim of this project is to characterize complement evasion molecules in the opportunistic bacterium Klebsiella pneumoniae (K. pneumoniae) where carbapenem-resistance grew from 1.6% to 10.4% in 10 years.
  Evaluation of fungal complement evasion mechanisms via the lectin pathway
  Prof P Garred, Prof J Koehl
Application Deadline: 10 November 2019

Funding Type

PhD Type

The group of professor Peter Garred at the University of Copenhagen has deciphered the components of the lectin complement pathway.
  Characterization of C5aR2 expression and function in Toxoplasma gondii infection
  Prof J Koehl, Prof D Wilflingseder
Application Deadline: 10 November 2019

Funding Type

PhD Type

Toxoplasma gondii (T. gondii) is a widespread obligate intracellular protozoan parasite. It is of major medical importance during pregnancy and in immunocompromised individuals.
  Single and double inhibition of complement and CD14 in opportunistic conditions
  Prof T Mollnes, Prof R Würzner, Prof P Garred
Application Deadline: 10 November 2019

Funding Type

PhD Type

The group of professor Mollnes has worked with a combined inhibition of complement (at the level of C3 and C5), and the Toll like receptors (TLRs) targeting CD14, a key co-receptor for TLR4, TLR2 and others, based on an hypothesis to attenuating the upstream innate immune activation when it is over- or dys-activated.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.